Skip to Content
Sara Best, MD

Contact Dr. Best

E-mail:
best@urology.wisc.edu

Phone:
(608) 263-9534

Mail:
UW Medical Foundation Centennial Building
1685 HIGHLAND AVE
MADISON, WI 53705-2281

Sara Best, MD

Assistant Professor (CHS)

Education

  • MD, University of Wisconsin Medical School, Madison, Wisconsin, 2003
  • Endourology Research Fellowship, University of Minnesota, 2004
  • Residency, University of Wisconsin, Madison, Wisconsin, 2009
  • Endourology and Minimally Invasive Urology Fellowship, University of Texas Southwestern, Dallas, Texas, 2011

Clinical Specialties

Dr. Best is certified by the American Board of Urology and specializes in minimally invasive surgical treatment of urologic cancers and stone disease. She has advanced training in laparoscopic and robotic surgery for kidney cancer, prostate cancer, and kidney/ureter reconstruction. She also manages patients with kidney stones, including the full range of surgical therapies and medical management. She has a special interest in performing robotic partial nephrectomies for kidney cancer. Her philosophy is to try to get patients back to their “normal lives” as quickly as possible by using minimally invasive approaches whenever possible.

Research Interests

Dr. Best’s research interests lie in the study of kidney cancer and disease using optics, the development of new technology for minimally invasive surgery, and urinary stone disease.

Recent Publications
  • Maciolek KA, Jarrard DF, Abel EJ, Best SL. Systematic Assessment Reveals Lack of Understandability for Prostate Biopsy Online Patient Education Materials. Urology 2017 Aug 02.
    [PubMed ID: 28780302]
    More Information
  • Wells SA, Wong VK, Wittmann TA, Lubner MG, Best SL, Ziemlewicz TJ, Hinshaw JL, Lee FT, Abel EJ. Renal mass biopsy and thermal ablation: should biopsy be performed before or during the ablation procedure? Abdom Radiol (NY) 2017 Jun; 42(6):1773-1780.
    [PubMed ID: 28184961]
    More Information
  • Bell JR, Penniston KL, Best SL, Nakada SY. A survey of patient preferences regarding medical expulsive therapy following the SUSPEND trial. Can J Urol 2017 Jun; 24(3):8827-8831.
    [PubMed ID: 28646938]
    More Information
  • Best SL, Abel EJ. Editorial Comment. J. Urol. 2017 May 17.
    [PubMed ID: 28527306]
    More Information
  • Best SL. Editorial Comment for Jones et al. J. Endourol. 2017 Apr; 31(4):341.
    [PubMed ID: 28322584]
    More Information
  • Best SL, Blute M, Lane B, Abel EJ. Surgical Treatment of 4-10 cm Renal-Cell Carcinoma: A Survey of the Lions and Gazelles. J. Endourol. 2017 Apr; 31(S1):S43-S47.
    [PubMed ID: 28326796]
    More Information
  • Richards KA, Cesario S, Lim AH, Best SL, Deeren SM, Bushman W, Safdar N. Utility of routine urinalysis and urine culture testing in an ambulatory urology clinic: a quality improvement initiative in a Veterans healthcare facility. Can J Urol 2017 Feb; 24(1):8627-8633.
    [PubMed ID: 28263127]
    More Information
  • Grimes MD, Blute ML, Wittmann TA, Mann MA, Zorn K, Downs TM, Shi F, Jarrard DF, Best SL, Richards KA, Nakada SY, Abel EJ. A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery. Urology 2016 Oct; 96():93-98.
    [PubMed ID: 27339026]
    More Information
  • Best SL. Erastus B. Wolcott: A Pioneer in Renal Surgery and Frontier Medicine. Urology 2016 Aug; 94():3-6.
    [PubMed ID: 27196031]
    More Information
  • Streeper NM, Nakada SY, Wertheim ML, Best SL. Preliminary Evidence Suggests Periureteral Botulinum Toxin Type A Injection Improves Ureteral Stone Passage in the Porcine Model. J. Endourol. 2016 Mar; 30(3):327-31.
    [PubMed ID: 26560963]
    More Information


webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System